Skip to main content
Top
Published in: Rheumatology International 10/2012

01-10-2012 | Short Communication

Systemic lupus erythematosus associated with ANCA-associated vasculitis: an overlapping syndrome?

Authors: B. Hervier, M. Hamidou, J. Haroche, C. Durant, A. Mathian, Z. Amoura

Published in: Rheumatology International | Issue 10/2012

Login to get access

Abstract

Systemic lupus erythematosus (SLE) and small-sized vessel vasculitis are usually two distinguishable autoimmune diseases. However, a vasculitis may be found in the course SLE but rarely corresponds to an ANCA-associated vasculitis (AAV). We report four cases of de novo SLE associated with AAV, our aim being to discuss the clinical significance of this association. We included four patients fulfilling the criteria for both SLE and AAV and followed in two different university hospitals between 1996 and 2009. In light of a 20-year literature review (25 described clinical cases), we discussed the etiopathogeny of such an association. All patients presented a severe renal involvement (creatininemia ranging from 120 to 370 μmol/l) and thrombopenia (ranging from 45,000 to 137,000 platelets/mm3). The other main clinical symptoms were arthritis (n = 3), serositis (n = 2) and intra-alveolar hemorrhage (n = 2). An inflammatory syndrome was noticed at diagnosis in all cases. ANCAs were MPO-ANCAs in all cases. Two out of these four patients were also diagnosed with antiphospholipid syndrome. The frequency of this association seems not fortuitous. Although the etiopathogenic mechanisms of such an association remain to be more precisely described, several clinical, histological and immunological features support the hypothesis of the existence of a SLE-AAV overlapping syndrome. Moreover, clinicians must be aware of such an overlapping syndrome, notably because its initial presentation can be very severe.
Literature
2.
go back to reference Renaudineau Y, Pers JO, Bendaoud B, Jamin C, Youinou P (2004) Dysfunctional B cells in systemic lupus erythematosus. Autoimmun Rev 3(7–8):516–523PubMedCrossRef Renaudineau Y, Pers JO, Bendaoud B, Jamin C, Youinou P (2004) Dysfunctional B cells in systemic lupus erythematosus. Autoimmun Rev 3(7–8):516–523PubMedCrossRef
3.
go back to reference Falk RJ, Jennette JC (2004) Thoughts about the classification of small vessel vasculitis. J Nephrol 17(Suppl 8):S3–S9PubMed Falk RJ, Jennette JC (2004) Thoughts about the classification of small vessel vasculitis. J Nephrol 17(Suppl 8):S3–S9PubMed
4.
go back to reference Sen D, Isenberg DA (2003) Antineutrophil cytoplasmic autoantibodies in systemic lupus erythematosus. Lupus 12(9):651–658PubMedCrossRef Sen D, Isenberg DA (2003) Antineutrophil cytoplasmic autoantibodies in systemic lupus erythematosus. Lupus 12(9):651–658PubMedCrossRef
5.
go back to reference Lee SS, Lawton JW, Chak W (1991) Distinction between antinuclear antibody and P-ANCA. J Clin Pathol 44(11):962–963PubMedCrossRef Lee SS, Lawton JW, Chak W (1991) Distinction between antinuclear antibody and P-ANCA. J Clin Pathol 44(11):962–963PubMedCrossRef
6.
go back to reference Arahata H, Migita K, Izumoto H, Miyashita T, Munakata H, Nakamura H, Tominaga M, Origuchi T, Kawabe Y, Hida A, Taguchi T, Eguchi K (1999) Successful treatment of rapidly progressive lupus nephritis associated with anti-MPO antibodies by intravenous immunoglobulins. Clin Rheumatol 18(1):77–81PubMedCrossRef Arahata H, Migita K, Izumoto H, Miyashita T, Munakata H, Nakamura H, Tominaga M, Origuchi T, Kawabe Y, Hida A, Taguchi T, Eguchi K (1999) Successful treatment of rapidly progressive lupus nephritis associated with anti-MPO antibodies by intravenous immunoglobulins. Clin Rheumatol 18(1):77–81PubMedCrossRef
7.
go back to reference Cavagna L, Caporali R, Esposito C, Augetti C, Epis O, Montecucco C (2007) Clinical features of ANCA-positive systemic lupus erythematosus: report of two cases. Scand J Rheumatol 36(1):74–76PubMedCrossRef Cavagna L, Caporali R, Esposito C, Augetti C, Epis O, Montecucco C (2007) Clinical features of ANCA-positive systemic lupus erythematosus: report of two cases. Scand J Rheumatol 36(1):74–76PubMedCrossRef
8.
go back to reference Hirai Y, Iyoda M, Shibata T, Ashikaga E, Hosaka N, Suzuki H, Nagai H, Mukai M, Honda H, Kuroki A, Kitazawa K, Akizawa T (2008) Lupus nephritis associated with positive MPO-ANCA in a patient with underlying autoimmune hemolytic anemia. Clin Exp Nephrol 12(5):393–397PubMedCrossRef Hirai Y, Iyoda M, Shibata T, Ashikaga E, Hosaka N, Suzuki H, Nagai H, Mukai M, Honda H, Kuroki A, Kitazawa K, Akizawa T (2008) Lupus nephritis associated with positive MPO-ANCA in a patient with underlying autoimmune hemolytic anemia. Clin Exp Nephrol 12(5):393–397PubMedCrossRef
9.
go back to reference Kobayashi S, Inokuma S (2009) Intrapulmonary haemorrhage in collagen-vascular diseases includes a spectrum of underlying conditions. Intern Med 48(11):891–897PubMedCrossRef Kobayashi S, Inokuma S (2009) Intrapulmonary haemorrhage in collagen-vascular diseases includes a spectrum of underlying conditions. Intern Med 48(11):891–897PubMedCrossRef
10.
go back to reference Nasr SH, D’Agati VD, Park HR, Sterman PL, Goyzueta JD, Dressler RM, Hazlett SM, Pursell RN, Caputo C, Markowitz GS (2008) Necrotizing and crescentic lupus nephritis with antineutrophil cytoplasmic antibody seropositivity. Clin J Am Soc Nephrol 3(3):682–690PubMedCrossRef Nasr SH, D’Agati VD, Park HR, Sterman PL, Goyzueta JD, Dressler RM, Hazlett SM, Pursell RN, Caputo C, Markowitz GS (2008) Necrotizing and crescentic lupus nephritis with antineutrophil cytoplasmic antibody seropositivity. Clin J Am Soc Nephrol 3(3):682–690PubMedCrossRef
11.
go back to reference Nishiya K, Chikazawa H, Nishimura S, Hisakawa N, Hashimoto K (1997) Anti-neutrophil cytoplasmic antibody in patients with systemic lupus erythematosus is unrelated to clinical features. Clin Rheumatol 16(1):70–75PubMedCrossRef Nishiya K, Chikazawa H, Nishimura S, Hisakawa N, Hashimoto K (1997) Anti-neutrophil cytoplasmic antibody in patients with systemic lupus erythematosus is unrelated to clinical features. Clin Rheumatol 16(1):70–75PubMedCrossRef
12.
go back to reference Spronk PE, Bootsma H, Horst G, Huitema MG, Limburg PC, Tervaert JW, Kallenberg CG (1996) Antineutrophil cytoplasmic antibodies in systemic lupus erythematosus. Br J Rheumatol 35(7):625–631PubMedCrossRef Spronk PE, Bootsma H, Horst G, Huitema MG, Limburg PC, Tervaert JW, Kallenberg CG (1996) Antineutrophil cytoplasmic antibodies in systemic lupus erythematosus. Br J Rheumatol 35(7):625–631PubMedCrossRef
13.
go back to reference Yu F, Tan Y, Liu G, Wang SX, Zou WZ, Zhao MH (2009) Clinicopathological characteristics and outcomes of patients with crescentic lupus nephritis. Kidney Int 76(3):307–317 Yu F, Tan Y, Liu G, Wang SX, Zou WZ, Zhao MH (2009) Clinicopathological characteristics and outcomes of patients with crescentic lupus nephritis. Kidney Int 76(3):307–317
14.
go back to reference Cambridge G, Wallace H, Bernstein RM, Leaker B (1994) Autoantibodies to myeloperoxidase in idiopathic and drug-induced systemic lupus erythematosus and vasculitis. Br J Rheumatol 33(2):109–114PubMedCrossRef Cambridge G, Wallace H, Bernstein RM, Leaker B (1994) Autoantibodies to myeloperoxidase in idiopathic and drug-induced systemic lupus erythematosus and vasculitis. Br J Rheumatol 33(2):109–114PubMedCrossRef
15.
go back to reference Galeazzi M, Morozzi G, Sebastiani GD, Bellisai F, Marcolongo R, Cervera R, De Ramon GE, Fernandez-Nebro A, Houssiau F, Jedryka-Goral A, Mathieu A, Papasteriades C, Piette JC, Scorza R, Smolen J (1998) Anti-neutrophil cytoplasmic anti bodies in 566 European patients with systemic lupus erythematosus: prevalence, clinical associations and correlation with other autoantibodies. European concerted action on the immunogenetics of SLE. Clin Exp Rheumatol 16(5):541–546PubMed Galeazzi M, Morozzi G, Sebastiani GD, Bellisai F, Marcolongo R, Cervera R, De Ramon GE, Fernandez-Nebro A, Houssiau F, Jedryka-Goral A, Mathieu A, Papasteriades C, Piette JC, Scorza R, Smolen J (1998) Anti-neutrophil cytoplasmic anti bodies in 566 European patients with systemic lupus erythematosus: prevalence, clinical associations and correlation with other autoantibodies. European concerted action on the immunogenetics of SLE. Clin Exp Rheumatol 16(5):541–546PubMed
16.
go back to reference Manolova I, Dancheva M, Halacheva K (2001) Antineutrophil cytoplasmic antibodies in patients with systemic lupus erythematosus: prevalence, antigen specificity, and clinical associations. Rheumatol Int 20(5):197–204PubMedCrossRef Manolova I, Dancheva M, Halacheva K (2001) Antineutrophil cytoplasmic antibodies in patients with systemic lupus erythematosus: prevalence, antigen specificity, and clinical associations. Rheumatol Int 20(5):197–204PubMedCrossRef
17.
go back to reference Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25(11):1271–1277PubMedCrossRef Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, Schaller JG, Talal N, Winchester RJ (1982) The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 25(11):1271–1277PubMedCrossRef
18.
go back to reference Chin HJ, Ahn C, Lim CS, Chung HK, Lee JG, Song YW, Lee HS, Han JS, Kim S, Lee JS (2000) Clinical implications of antineutrophil cytoplasmic antibody test in lupus nephritis. Am J Nephrol 20(1):57–63PubMedCrossRef Chin HJ, Ahn C, Lim CS, Chung HK, Lee JG, Song YW, Lee HS, Han JS, Kim S, Lee JS (2000) Clinical implications of antineutrophil cytoplasmic antibody test in lupus nephritis. Am J Nephrol 20(1):57–63PubMedCrossRef
19.
go back to reference Falk RJ, Jennette JC (1988) Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis. N Engl J Med 318(25):1651–1657PubMedCrossRef Falk RJ, Jennette JC (1988) Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis. N Engl J Med 318(25):1651–1657PubMedCrossRef
20.
go back to reference Lee SS, Lawton JW, Chan CE, Li CS, Kwan TH, Chau KF (1992) Antilactoferrin antibody in systemic lupus erythematosus. Br J Rheumatol 31(10):669–673PubMedCrossRef Lee SS, Lawton JW, Chan CE, Li CS, Kwan TH, Chau KF (1992) Antilactoferrin antibody in systemic lupus erythematosus. Br J Rheumatol 31(10):669–673PubMedCrossRef
21.
go back to reference Marshall S, Dressler R, D’Agati V (1997) Membranous lupus nephritis with antineutrophil cytoplasmic antibody-associated segmental necrotizing and crescentic glomerulonephritis. Am J Kidney Dis 29(1):119–124PubMedCrossRef Marshall S, Dressler R, D’Agati V (1997) Membranous lupus nephritis with antineutrophil cytoplasmic antibody-associated segmental necrotizing and crescentic glomerulonephritis. Am J Kidney Dis 29(1):119–124PubMedCrossRef
22.
go back to reference Merkel PA, Polisson RP, Chang Y, Skates SJ, Niles JL (1997) Prevalence of antineutrophil cytoplasmic antibodies in a large inception cohort of patients with connective tissue disease. Ann Intern Med 126(11):866–873PubMed Merkel PA, Polisson RP, Chang Y, Skates SJ, Niles JL (1997) Prevalence of antineutrophil cytoplasmic antibodies in a large inception cohort of patients with connective tissue disease. Ann Intern Med 126(11):866–873PubMed
23.
go back to reference Nassberger L, Sjoholm AG, Jonsson H, Sturfelt G, Akesson A (1990) Autoantibodies against neutrophil cytoplasm components in systemic lupus erythematosus and in hydralazine-induced lupus. Clin Exp Immunol 81(3):380–383PubMedCrossRef Nassberger L, Sjoholm AG, Jonsson H, Sturfelt G, Akesson A (1990) Autoantibodies against neutrophil cytoplasm components in systemic lupus erythematosus and in hydralazine-induced lupus. Clin Exp Immunol 81(3):380–383PubMedCrossRef
24.
go back to reference Akhtar M, al Dalaan A, el Ramahi KM (1994) Pauci-immune necrotizing lupus nephritis: report of two cases. Am J Kidney Dis 23(2):320–325PubMed Akhtar M, al Dalaan A, el Ramahi KM (1994) Pauci-immune necrotizing lupus nephritis: report of two cases. Am J Kidney Dis 23(2):320–325PubMed
25.
go back to reference Lamprecht P (2005) Off balance: T-cells in antineutrophil cytoplasmic antibody (ANCA)-associated vasculitides. Clin Exp Immunol 141(2):201–210PubMedCrossRef Lamprecht P (2005) Off balance: T-cells in antineutrophil cytoplasmic antibody (ANCA)-associated vasculitides. Clin Exp Immunol 141(2):201–210PubMedCrossRef
26.
go back to reference Masutani K, Tokumoto M, Nakashima H, Tsuruya K, Kashiwagi M, Kudoh Y, Fukuda K, Kanai H, Akahoshi M, Otsuka T, Hirakata H, Iida M (2003) Strong polarization toward Th1 immune response in ANCA-associated glomerulonephritis. Clin Nephrol 59(6):395–405PubMed Masutani K, Tokumoto M, Nakashima H, Tsuruya K, Kashiwagi M, Kudoh Y, Fukuda K, Kanai H, Akahoshi M, Otsuka T, Hirakata H, Iida M (2003) Strong polarization toward Th1 immune response in ANCA-associated glomerulonephritis. Clin Nephrol 59(6):395–405PubMed
27.
go back to reference Calvani N, Tucci M, Richards HB, Tartaglia P, Silvestris F (2005) Th1 cytokines in the pathogenesis of lupus nephritis: the role of IL-18. Autoimmun Rev 4(8):542–548PubMedCrossRef Calvani N, Tucci M, Richards HB, Tartaglia P, Silvestris F (2005) Th1 cytokines in the pathogenesis of lupus nephritis: the role of IL-18. Autoimmun Rev 4(8):542–548PubMedCrossRef
28.
go back to reference Deng C, Lu Q, Zhang Z, Rao T, Attwood J, Yung R, Richardson B (2003) Hydralazine may induce autoimmunity by inhibiting extracellular signal-regulated kinase pathway signalling. Arthritis Rheum 48(3):746–756PubMedCrossRef Deng C, Lu Q, Zhang Z, Rao T, Attwood J, Yung R, Richardson B (2003) Hydralazine may induce autoimmunity by inhibiting extracellular signal-regulated kinase pathway signalling. Arthritis Rheum 48(3):746–756PubMedCrossRef
Metadata
Title
Systemic lupus erythematosus associated with ANCA-associated vasculitis: an overlapping syndrome?
Authors
B. Hervier
M. Hamidou
J. Haroche
C. Durant
A. Mathian
Z. Amoura
Publication date
01-10-2012
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 10/2012
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-011-2055-z

Other articles of this Issue 10/2012

Rheumatology International 10/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.